AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home mLife Article
PDF (1.8 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Assessing global fungal threats to humans

Department of Biology and Institute of Infectious Diseases Research, McMaster University, Hamilton, Ontario, Canada

Edited by Lei Cai, Institute of Microbiology, Chinese Academy of Sciences, China

Show Author Information

Abstract

Fungi are an integral part of the earth's biosphere. They are broadly distributed in all continents and ecosystems and play a diversity of roles. Here, I review our current understanding of fungal threats to humans and describe the major factors that contribute to various threats. Among the 140,000 or so known species out of the estimated six million fungal species on Earth, about 10% directly or indirectly threaten human health and welfare. Major threats include mushroom poisoning, fungal allergies, infections of crop plants, food contamination by mycotoxins, and mycoses in humans. A growing number of factors have been identified to impact various fungal threats, including human demographics, crop distributions, anthropogenic activities, pathogen dispersals, global climate change, and/or the applications of antifungal drugs and agricultural fungicides. However, while models have been developed for analyzing various processes of individual threats and threat managements, current data are primarily descriptive and incomplete, and there are significant obstacles to integration of the diverse factors into accurate quantitative assessments of fungal threats. With increasing technological advances and concerted efforts to track the spatial and temporal data on climate and environmental variables; mycotoxins in the feed and food supply chains; fungal population dynamics in crop fields, human and animal populations, and the environment; human population demographics; and the prevalence and severities of fungal allergies and diseases, our ability to accurately assess fungal threats will improve. Such improvements should help us develop holistic strategies to manage fungal threats in the future.

References

1
Konopka JB, Casadevall A, Taylor JW, Heitman J, Cowen L. Onehealth: fungal pathogens of humans, animals, and plants. Colloquiumreport. Washington: American Society for Microbiology; 2019.
2

Kohler JR, Hube B, Puccia R, Casadevall A, Perfect JR. Fungi that infect humans. Microbiol Spectr. 2017;5:813–43.

3

Scott P, Strange R, Korsten L, Gullino ML. Plant diseases and food security in the 21st century. The Netherlands: Springer; 2021.

4

Fones HN, Bebber DP, Chaloner TM, Kay WT, Steinberg G, Gurr SJ. Threats to global food security from emerging fungal and oomycete crop pathogens. Nat Food. 2020;1:332–42.

5

Alshannaq A, Yu JH. Occurrence, toxicity, and analysis of major mycotoxins in food. Int J Environ Res Public Health. 2017;14:632.

6

Mari A, Schneider P, Wally V, Breitenbach M, Simon-Nobbe B. Sensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extracts. Clin Exp Allergy. 2003;33:1429–38.

7

Denning DW, Pashley C, Hartl D, Wardlaw A, Godet C, Del Giacco S, et al. Fungal allergy in asthma-state of the art and research needs. Clin Transl Allergy. 2014;4:14.

8

Li W, Pires SM, Liu Z, Liang J, Wang Y, Chen W, et al. Mushroom poisoning outbreaks—China, 2010–2020. China CDC Weekly. 2021;3:518–22.

9

Wu F, Zhou LW, Yang ZL, Bau T, Li TH, Dai YC. Resource diversity of Chinese macrofungi: edible, medicinal and poisonous species. Fungal Divers. 2019;98:1–76.

10

Hall IR, Stephenson SL, Buchanan PK, Wang Y, Cole ALJ. Edible and poisonous mushrooms of the world. Portland: Timber Press; 2010.

11
Boa E. Wild Edible Fungi: a global overview of their use and importance to people. Rome: Food and Agriculture Organization of theUnited Nations; 2004.
12

Brandenburg WE, Ward KJ. Mushroom poisoning epidemiology in the United States. Mycologia. 2018;110:637–41.

13

Sinno-Tellier S, Bruneau C, Daoudi J, Greillet C, Verrier A, Bloch J. Surveillance nationale des intoxications alimentaires par des champignons: bilan des cas rapportés au réseau des centres antipoison de 2010 à 2017 en France métropolitaine. Bull Epidémiol Hebd. 2019;33:666–78.

14

Li H, Zhang H, Zhang Y, Zhou J, Yin Y, He Q, et al. Mushroom poisoning outbreaks — China, 2021. China CDC Weekly. 2022;4:35–40.

15

Betancor D, Nuñez-Borque E, Cuesta-Herranz J, Escudero C, Freundt N, Pastor-Vargas C, et al. Orin: a new button mushroom (Agaricus bisporus) allergen. J Investig Allergol Clin Immunol. 2020;30:135–6.

16

Zhong J, Xu J, Zhang P. Diversity, dispersal and mode of reproduction of Amanita exitialis in Southern China. Genes. 2021;12:1907.

17

He Z, Long P, Fang F, Li S, Zhang P, Chen Z. Diversity of MSDIN family members in amanitin-producing mushrooms and the phylogeny of the MSDIN and prolyl oligopeptidase genes. BMC Genomics. 2020;21:440.

18

Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, et al. Diversity, biology, and history of psilocybin-containing fungi: suggestions for research and technological development. Fungal Biol. 2022;126:308–19.

19

Fricke J, Lenz C, Wick J, Blei F, Hoffmeister D. Production options for psilocybin: making of the magic. Chemistry. 2019;25:897–903.

20

Boyce GR, Gluck-Thaler E, Slot JC, Stajich JE, Davis WJ, James TY, et al. Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogens. Fungal Ecol. 2019;41:147–64.

21

Pomés A, Davies JM, Gadermaier G, Hilger C, Holzhauser T, Lidholm J, et al. WHO/IUIS allergen nomenclature: providing a common language. Mol Immunol. 2018;100:3–13.

22

Crameri R, Garbani M, Rhyner C, Huitema C. Fungi: the neglected allergenic sources. Allergy. 2014;69:176–85.

23

Taylor G, Walker J. Charles Harrison Blackley, 1820–1900. Clin Exp Allergy. 1973;3:103–8.

24

Denning DW, Pashley C, Hartl D, Wardlaw A, Godet C, Del Giacco S, et al. Fungal allergy in asthma-state of the art and research needs. Clin Transl Allergy. 2014;4:14.

25

Paudel B, Chu T, Chen M, Sampath V, Prunicki M, Nadeau KC. Increased duration of pollen and mold exposure are linked to climate change. Sci Rep. 2021;11:12816.

26

Anees-Hill S, Douglas P, Pashley CH, Hansell A, Marczylo EL. A systematic review of outdoor airborne fungal spore seasonality across Europe and the implications for health. Sci Total Environ. 2022;818:151716.

27

Hanson MC, Petch GM, Ottosen T-B, Skjøth CA. Climate change impact on fungi in the atmospheric microbiome. Sci Total Environ. 2022;830:154491.

28

Beasley R, ISAAC Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998;351:1225–32.

29

Graham-Rowe D. Lifestyle: when allergies go west. Nature. 2011;479:S2–4.

30

Safatov AS, Andreeva IS, Buryak GA, Olkin SE, Reznikova IK, Belan BD, et al. Long-term studies of biological components of atmospheric aerosol: trends and variability. Atmosphere. 2022;13:651.

31

Abu-Dieyeh MH, Barham R, Abu-Elteen K, Al-Rashidi R, Shaheen I. Seasonal variation of fungal spore populations in the atmosphere of Zarqa area, Jordan. Aerobiologia. 2010;26:263–76.

32

Crameri R. Allergy diagnosis, allergen repertoires, and their implication in allergen-specific immunotherapy. Immunol Allergy Clin North Am. 2006;26:179–89.

33

Lee SP, Shin YS, Kang SY, Kim TB, Lee SM. Recent advances in allergen-specific immunotherapy in humans: a systematic review. Immune Netw. 2022;22:e12.

34
FAO, IFAD, UNICEF, WFP, WHO. The state of food security and nutrition in the world 2021: transforming food systems for food security, improved nutrition and affordable healthy diets for all. Rome: FAO; 2021.
35

Xu J. Origins and spread of plant fungal and oomycete disease outbreaks. J Plant Prot. 2022;49:283–97.

36

Boland GJ, Hall R. Index of plant hosts of Sclerotinia sclerotiorum. Can J Plant Pathol. 1994;16:93–108.

37

Dweba CC, Figlan S, Shimelis HA, Motaung TE, Sydenham S, Mwadzingeni L, et al. Fusarium head blight of wheat: pathogenesis and control strategies. Crop Prot. 2017;91:114–22.

38

Kihoro J, Bosco NJ, Murage H, Ateka E, Makihara D. Investigating the impact of rice blast disease on the livelihood of the local farmers in greater Mwea region of Kenya. Springerplus. 2013;2:308.

39

Corredor-Moreno P, Saunders DGO. Expecting the unexpected: factors influencing the emergence of fungal and oomycete plant pathogens. New Phytol. 2020;225:118–25.

40

Fabre F, Burie J-B, Ducrot A, Lion S, Richard Q, Djidjou-Demasse R. An epi-evolutionary model for predicting the adaptation of spore-producing pathogens to quantitative resistance in heterogeneous environments. Evol Appl. 2022;15:95–110.

41

Cunniffe NJ, Cobb RC, Meentemeyer RK, Rizzo DM, Gilligan CA. Modeling when, where, and how to manage a forest epidemic, motivated by sudden oak death in California. Proc Natl Acad Sci USA. 2016;113:5640–5.

42

Cunniffe NJ, Koskella B, Metcalf CJE, Parnell S, Gottwald TR, Gilligan CA. Thirteen challenges in modelling plant diseases. Epidemics. 2015;10:6–10.

43

Bebber DP, Ramotowski MAT, Gurr SJ. Crop pests and pathogens move polewards in a warming world. Nat Clim Change. 2013;3:985–8.

44

Chen J, Li Z, Cheng Y, Gao C, Guo L, Wang T, et al. Sphinganine-analog mycotoxins (SAMs): chemical structures, bioactivities, and genetic controls. J Fungi. 2020;6:312.

45

Meyer V, Basenko EY, Benz JP, Braus GH, Caddick MX, Csukai M, et al. Growing a circular economy with fungal biotechnology: a white paper. Fungal Biol Biotechnol. 2020;7:5.

46

Mitchell NJ, Bowers E, Hurburgh C, Wu F. Potential economic loss to the US corn industry from aflatoxin contamination. Food Addit Contam Part A. 2016;33:540–50.

47

Dlamini C, Earnshaw D, Assefa Y. Temporal trends in mycotoxin contaminations in maize supplied to consumers in Eswatini. Int J Food Sci Agri. 2022;6:128–34.

48

Ankwasa EM, Francis I, Ahmad T. Update on mycotoxin contamination of maize and peanuts in East African Community Countries. J Food Sci Nutr. 2021;7:1–10.

49

Bouakline A, Lacroix C, Roux N, Gangneux JP, Derouin F. Fungal contamination of food in hematology units. J Clin Microbiol. 2000;38:4272–3.

50

Tabari H. Climate change impact on flood and extreme precipitation increases with water availability. Sci Rep. 2020;10:13768.

51

Ropejko K, Twarużek M. Zearalenone and its metabolites—general overview, occurrence, and toxicity. Toxins. 2021;13:35.

52

Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg. 2017;21:525–39.

53

Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi. 2017;3:57.

54

Thompson RN, Brooks-Pollock E. Detection, forecasting and control of infectious disease epidemics: modelling outbreaks in humans, animals and plants. Philos Trans R Soc B. 2019;374:20190038.

55

Siettos CI, Russo L. Mathematical modeling of infectious disease dynamics. Virulence. 2013;4:295–306.

56

Schwartz IS, Govender NP, Sigler L, Jiang Y, Maphanga TG, Toplis B, et al. Emergomyces: the global rise of new dimorphic fungal pathogens. PLoS Pathog. 2019;15:e1007977.

57
Ning C, Wei W, Xu B. The global distribution, drivers, and burden oftalaromycosis 1964–2018. Conference of Retrovirus and Opportunistic Infections; Boston, MA, USA; March 8–11, 2020 (abstract 749).
58

Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis. 2018;68:1791–7.

59

Wu JY, Zhou DY, Zhang Y, Mi F, Xu J. Analyses of the global multilocus genotypes of the human pathogenic yeast Candida tropicalis. Front Microbiol. 2019;10:900.

60

Korfanty G, Teng L, Pum N, Xu J. Contemporary gene flow is a major force shaping the Aspergillus fumigatus population in Auckland, New Zealand. Mycopathologia. 2019;184:479–92.

61

Arora P, Singh P, Wang Y, Yadav A, Pawar K, Singh A, et al. Environmental isolation of Candida auris from the coastal wetlands of Andaman Islands, India. mBio. 2021;12:e03181–20.

62

Samarasinghe H, Lu Y, Aljohani R, Al-Amad A, Yoell H, Xu J. Global patterns in culturable soil yeast diversity. iScience. 2021;24:103098.

63

Korfanty GA, Dixon M, Jia H, Yoell H, Xu J. Genetic diversity and dispersal of Aspergillus fumigatus in Arctic soils. Genes. 2022;13:19.

64

Liu Y, Chen Z, Li J, Zhu Z, Pang S, Xu J, et al. Extensive diversity and prevalent fluconazole resistance among environmental yeasts from tropical China. Genes. 2022;13:444.

65

Yadav A, Jain K, Wang Y, Pawar K, Kaur H, Sharma K, et al. Candida auris on apples: diversity and clinical significance. mBio. 2022;13:e00518–22.

66

Samarasinghe H, You M, Jenkinson TS, Xu J, James TY. Hybridization facilitates adaptive evolution in two major fungal pathogens. Genes. 2020;11:101.

67

Delgado-Baquerizo M, Guerra CA, Cano-Díaz C, Egidi E, Wang J-T, Eisenhauer N, et al. The proportion of soil-borne pathogens increases with warming at the global scale. Nat Clim Change. 2020;10:550–4.

68

Zhou D, Korfanty GA, Mo M, Wang R, Li X, Li H, et al. Extensive genetic diversity and widespread azole resistance in greenhouse populations of Aspergillus fumigatus in Yunnan, China. mSphere. 2021;6:e00066–21.

69

Yang G, Cui S, Ma N, Song Y, Ma J, Huang W, et al. Genetic structure and triazole antifungal susceptibilities of Alternaria alternata from greenhouses in Kunming, China. Microbiol Spectr. 2022;5:e0038222.

70

Chowdhary A, Kathuria S, Xu J, Meis JF. Emergence of azole resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog. 2013;9:e1003633.

71

Karsten E, Watson SL, Foster LJ. Diversity of microbial species implicated in keratitis: a review. Open Ophthalmol J. 2012;6:110–24.

72

Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51:2–15.

73

Yamamura D, Xu J. Update on pulmonary cryptococcosis. Mycopathologia. 2021;186:717–28.

74

Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48:1366–77.

75

Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol. 2005;43:284–92.

76

Kumar A, Prakash A, Singh A, Kumar H, Hagen F, Meis JF, et al. Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses. Emerg Microbes Infect. 2016;5:e49.

77

Xu J. Fungal species concepts in the genomics era. Genome. 2020;63:459–68.

78

Hirayama T, Miyazaki T, Yamagishi Y, Mikamo H, Ueda T, Nakajima K, et al. Clinical and microbiological characteristics of Candida guilliermondii and Candida fermentati. Antimicrob Agents Chemother. 2018;62:e02528–17.

79

Horré R, de Hoog GS. Primary cerebral infections by melanized fungi: a review. Stud Mycol. 1999;43:176–93.

80

Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53:41–4.

81

Wang Y, Xu J. Population genomic analyses reveal evidence for limited recombination in the superbug Candida auris in nature. Comput Struct Biotechnol J. 2022;20:3030–40.

82
CDC. Multistate outbreak of fungal meningitis and otherinfections–case count [Internet]. 2015. Available from: https://www.cdc.gov/hai/outbreaks/meningitis-map-large.html.
83

Hyde KD, Al-Hatmi AMS, Andersen B, Boekhout T, Buzina W, Dawson TL Jr., et al. The world's ten most feared fungi. Fungal Divers. 2018;93:161–94.

84

Baddley JW, Thompson GR 3rd, Chen SC, White PL, Johnson MD, Nguyen MH, et al. Coronavirus disease 2019-associated invasive fungal infection. Open Forum Infect Dis. 2021;8:ofab510.

85

Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022;20:557–71.

86

Oliveira LVN, Wang R, Specht CA, Levitz SM. Vaccines for human fungal diseases: close but still a long way to go. NPJ Vaccines. 2021;6:33.

87

Lu Y, Wang R, Zhang Y, Su H, Wang P, Jenkins A, et al. Ecosystem health towards sustainability. Ecosyst Health Sustain. 2015;1:2.

88

Forsythe A, Vanderwolf KJ, Xu J. Landscape genetic connectivity and evidence for recombination in the North American population of the white-nose syndrome pathogen, Pseudogymnoascus destructans. J Fungi. 2021;7:182.

mLife
Pages 223-240
Cite this article:
Xu J. Assessing global fungal threats to humans. mLife, 2022, 1(3): 223-240. https://doi.org/10.1002/mlf2.12036

370

Views

10

Downloads

37

Crossref

37

Web of Science

38

Scopus

0

CSCD

Altmetrics

Received: 26 June 2022
Accepted: 06 August 2022
Published: 22 September 2022
© 2022 The Authors. mLife published by John Wiley & Sons Australia, Ltd. on behalf of Institute of Microbiology, Chinese Academy of Sciences.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Return